KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Rigel Pharmaceuticals (RIGL) over the last 9 years, with Q3 2025 value amounting to $467000.0.

  • Rigel Pharmaceuticals' Amortizatization of Intangibles rose 57681.16% to $467000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 7070.71%. This contributed to the annual value of $709000.0 for FY2024, which is 4801.67% up from last year.
  • Rigel Pharmaceuticals' Amortizatization of Intangibles amounted to $467000.0 in Q3 2025, which was up 57681.16% from $250000.0 recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Amortizatization of Intangibles peaked at $467000.0 during Q3 2025, and registered a low of -$116000.0 during Q4 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $69000.0 (2024), whereas its average is $98473.7.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first plummeted by 69000.0% in 2022, then skyrocketed by 126666.67% in 2023.
  • Rigel Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$116000.0 in 2021, then soared by 254.31% to $179000.0 in 2022, then soared by 45.25% to $260000.0 in 2023, then increased by 6.15% to $276000.0 in 2024, then surged by 69.2% to $467000.0 in 2025.
  • Its Amortizatization of Intangibles was $467000.0 in Q3 2025, compared to $250000.0 in Q2 2025 and $190000.0 in Q1 2025.